Zhuoli Zhang

Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.

L. Wang, X. Zhang, Y. Fan, 2018, Clinical and experimental rheumatology.

The mTOR pathway in the antiphospholipid syndrome

L. Ji, Zhuoli Zhang, Andras Perl, 2023, Medical Review.

B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single‐arm cohort study of telitacicept

L. Ji, Y. Geng, Xiaohui Zhang, 2024, MedComm.

Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

E. Inoue, S. Navarra, J. Kikuchi, 2024, Annals of the rheumatic diseases.

Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis.

L. Ji, Hong Huang, Yu Wang, 2024, Mayo Clinic proceedings.

Real-world effectiveness of belimumab in patients with lupus in China: RELIABLE observational cohort study protocol

Patricia Juliao, Zhuoli Zhang, Zhiliu Tang, 2024, Lupus science & medicine.